By: Sheryl A. Kluberg, Andrew L. Simon, Sarah M. Alam, Alexander Peters, Casie Horgan, Dongdong Li, Erick Moyneur, Elizabeth Messenger-Jones , Richard Platt, Cheryl N. McMahill-Walraven, Djeneba Audrey Djibo, Kimberly Daniels, Aziza Jamal-Alliale, Claire H. Pernar, Najat J. Ziyadeh Qianli Ma, Mano Selvan, O'Mareen Spence, Driss Oraichi, Harry Seifert, Huifeng Yun
To assess whether recombinant zoster vaccine (RZV) is associated with an increased risk of new-onset gout among US adults aged ≥50 years.
Read more: ScienceDirect